Perfluorooctyl bromide has limited membrane solubility and is located at the bilayer center. Locating small molecules in lipid bilayers through paramagnetic enhancements of NMR relaxation

被引:18
作者
Ellena, JF
Obraztsov, VV
Cumbea, VL
Woods, CM
Cafiso, DS
机构
[1] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA
[2] Univ Virginia, Biophys Program, Charlottesville, VA 22904 USA
[3] Alliance Pharmaceut Corp, Dept Biol Res, San Diego, CA 92121 USA
关键词
D O I
10.1021/jm020278x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
There is considerable interest in the use of perfluorocarbons as oxygen carriers in clinical settings; however, little is known regarding the molecular interactions made by these apolar compounds with biological membranes or their effect on membrane structure. NMR spectroscopy was used to investigate the interaction of perfluorooctyl bromide (PFOB) with 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayers. F-19 NMR spectra demonstrate that PFOB partitions into POPC bilayers but that it saturates at a remarkably low membrane concentration of approximately 2 mol %. F-19 chemical shifts indicate that this membrane-bound PFOB experiences a local environment similar in polarity to that of hexane, suggesting that the compound resides within the hydrocarbon core of the lipid bilayer. This hydrocarbon location was refined by measuring paramagnetic enhancements of F-19 nuclear relaxation for membrane-bound PFOB produced by Gd3+ and O-2. The data clearly localize PFOB to the center of the membrane hydrocarbon and show how paramagnetic enhancements of nuclear relaxation produced by O-2 may be used to localize small molecules within bilayerS. H-2 and P-31 NMR experiments demonstrate that PFOB produces no significant changes in either acyl chain or headgroup structure even at saturating membrane concentrations.
引用
收藏
页码:5534 / 5542
页数:9
相关论文
共 42 条
[31]  
SMITH D, 1997, AM J RESP CRIT CARE, V155, pA752
[32]   RELAXATION PROCESSES IN A SYSTEM OF 2 SPINS [J].
SOLOMON, I .
PHYSICAL REVIEW, 1955, 99 (02) :559-565
[33]   Perflubron emulsion delays blood transfusions in orthopedic surgery [J].
Spahn, DR ;
van Brempt, R ;
Theilmeier, G ;
Reibold, JP ;
Welte, M ;
Heinzerling, H ;
Birck, KM ;
Keipert, PE ;
Messmer, K .
ANESTHESIOLOGY, 1999, 91 (05) :1195-1208
[34]   Liquid ventilation attenuates pulmonary oxidative damage [J].
Steinhorn, DM ;
Papo, MC ;
Rotta, AT ;
Aljada, A ;
Fuhrman, BP ;
Dandona, P .
JOURNAL OF CRITICAL CARE, 1999, 14 (01) :20-28
[35]   OXYGEN PERMEABILITY OF PHOSPHATIDYLCHOLINE CHOLESTEROL MEMBRANES [J].
SUBCZYNSKI, WK ;
HYDE, JS ;
KUSUMI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) :4474-4478
[36]   Different distribution of fluorinated anesthetics and nonanesthetics in model membrane: A F-19 NMR study [J].
Tang, P ;
Yan, B ;
Xu, Y .
BIOPHYSICAL JOURNAL, 1997, 72 (04) :1676-1682
[37]   Perflubron decreases inflammatory cytokine production by human alveolar macrophages [J].
Thomassen, MJ ;
Buhrow, LT ;
Wiedemann, HP .
CRITICAL CARE MEDICINE, 1997, 25 (12) :2045-2047
[38]  
TUTUNCU AS, 1993, AM REV RESPIR DIS, V148, P785
[39]   Hydrophobic interactions of peptides with membrane interfaces [J].
White, SH ;
Wimley, WC .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES, 1998, 1376 (03) :339-352
[40]  
Wolfson MR, 1998, PEDIATR PULM, V26, P42, DOI 10.1002/(SICI)1099-0496(199807)26:1<42::AID-PPUL8>3.0.CO